Song Shiming, Yao Zhicui, Zhang Man, Ren Peng, Hu Huanyu, Li Zengning
Department of Clinical Nutrition, The First Hospital of Hebei Medical University, Hebei Province Key Laboratory of Nutrition and Health, Shijiazhuang 050031, China.
Department of Nursing, The First Hospital of Hebei Medical University, Shijiazhuang 050031, China.
Wei Sheng Yan Jiu. 2023 Mar;52(2):239-245. doi: 10.19813/j.cnki.weishengyanjiu.2023.02.011.
To explore the dose-effect and mechanism of the protective effect of corn peptide(CP) on nonalcoholic fatty liver disease(NAFLD).
Seventy male SD rats were randomly divided into control group, model group, CP group, puerarin positive control group, low-, medium-, high-dose corn peptide group, the experiment started after 1 week of adaptive feeding. The control group and CP group were fed with ordinary feed and others were fed with high-fat feed, while the control group was given intragastric administration of purified water, the CP group and the low-, medium-, high-dose corn peptide group were given intragastric administration of corn peptide(800, 400, 600 and 800 mg/(kg·d), respectively), and the puerarin positive control group was given intragastric administration of 300 mg/(kg·d) of puerarin, for 10 weeks. The body weight and general condition of rats were recorded every week, after 10 weeks, the indexes of 7 groups were compared.
Compared with the model group, the liver index(3.67, 3.29, 3.19 and 3.04, P<0.05) of the rats in the three doses of corn peptide groups decreased. The homeostasis model assessment of insulin resistance(13.66, 11.82, 11.55 and 10.53, P<0.05) decreased. The serum triglyceride(TG)(0.59, 0.42, 0.34 and 0.28, P<0.05), total cholesterol(TC)(2.57, 2.10, 1.67 and 1.46, P<0.05), free fatty acid(FFA)(0.66, 0.44, 0.40 and 0.36, P<0.05), and leptin(10.64, 9.87, 9.43 and 9.05, P<0.05) decreased. The serum interleukin-6(74.61, 61.66, 51.12 and 35.68, P<0.05) and tumor necrosis factor-α(100.18, 74.13, 67.44 and 48.46, P<0.05) decreased. The serum aspartate aminotransferase(41.38, 19.41, 14.98 and 8.44, P<0.05) and alanine aminotransferase(25.14, 13.10, 11.57 and 7.48, P<0.05) activity decreased. The liver TG(9.89, 5.55, 4.73 and 3.13, P<0.05), TC(1.73, 0.97, 0.80 and 0.50, P<0.05) and FFA(1.81, 1.11, 0.77 and 0.70, P<0.05) decreased. The serum malondialdehyde(MDA)(21.36, 15.24, 12.75 and 10.87, P<0.05) level and liver MDA(11.87, 8.27, 6.33 and 4.98, P<0.05) level decreased. The serum and liver superoxide dismutase and glutathione peroxidase activity increased(P<0.05), and the effect is related to the intervention dose of corn peptide. The size of the liver became smaller, the liver color gradually changed from light yellow to light red.
Corn peptide has a certain preventive effect on NAFLD in rats, and the preventive effect of corn peptide is related to its intervention dose.
探讨玉米肽(CP)对非酒精性脂肪性肝病(NAFLD)保护作用的剂量效应及机制。
将70只雄性SD大鼠随机分为对照组、模型组、CP组、葛根素阳性对照组、低、中、高剂量玉米肽组,适应性喂养1周后开始实验。对照组和CP组喂普通饲料,其余喂高脂饲料,对照组灌胃纯净水,CP组及低、中、高剂量玉米肽组分别灌胃玉米肽(800、400、600和800mg/(kg·d)),葛根素阳性对照组灌胃300mg/(kg·d)葛根素,持续10周。每周记录大鼠体重和一般状况,10周后比较7组各项指标。
与模型组相比,三个剂量玉米肽组大鼠的肝指数(3.67、3.29、3.19和3.04,P<0.05)降低。胰岛素抵抗稳态模型评估值(13.66、11.82、11.55和10.53,P<0.05)降低。血清甘油三酯(TG)(0.59、0.42、0.34和0.28,P<0.05)、总胆固醇(TC)(2.57、2.10、1.67和1.46,P<0.05)、游离脂肪酸(FFA)(0.66、0.44、0.40和0.36,P<0.05)及瘦素(10.64、9.87、9.43和9.05,P<0.05)降低。血清白细胞介素-6(74.61、61.66、51.12和35.68,P<0.05)和肿瘤坏死因子-α(100.18、74.13、67.44和48.46,P<0.05)降低。血清天冬氨酸转氨酶(41.38、19.41、14.98和8.44,P<0.05)和丙氨酸转氨酶(25.14、13.10、11.57和7.48,P<0.05)活性降低。肝脏TG(9.89、5.55、4.73和3.13,P<0.05)、TC(1.73、0.97、0.80和0.50,P<0.05)及FFA(1.81、1.11、0.77和0.70,P<0.05)降低。血清丙二醛(MDA)(21.36、15.24、12.